GlassScriptPhysician profile
Mehul R Bhalja
NPI 1790031276
$11,601.77
in general payments reported to CMS, 2019-2025
39 companies · $966 in 2025
The $966 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,460 · 2020: $781 · 2021: $972 · 2022: $819 · 2023: $1,059 · 2024: $545 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,569.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,812.75 | 2019 | |
| Edwards Lifesciences Corporation | $1,464.05 | 2019 | |
| Abbott Laboratories | $1,341.41 | 2019-2025 | Jot Dx, Diamondback Coronary, Esprit |
| Novartis Pharmaceuticals Corporation | $1,000.97 | 2019-2025 | |
| Pfizer INC. | $722.31 | 2019-2025 | |
| Terumo Medical Corporation | $548.00 | 2019 | |
| Abiomed | $464.00 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $460.05 | 2020-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $309.31 | 2021-2025 | Lifevest |
| Bard Peripheral Vascular, INC. | $304.06 | 2020 | |
| Angiodynamics, INC. | $302.28 | 2023 | Auryon Laser System 100-120 Vac, Alphavac |
| Kestra Medical Technology Services, INC. | $189.87 | 2025 | Assure Wcd |
| Amgen INC. | $150.72 | 2020-2025 | Repatha, Repatha |
| Inari Medical, INC. | $131.00 | 2020-2022 | |
| Boston Scientific Corporation | $115.61 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $107.96 | 2022-2025 | Verquvo, Winrevair |
| Janssen Pharmaceuticals, INC | $92.69 | 2019-2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $92.35 | 2019-2022 | |
| Shockwave Medical, INC | $92.18 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $87.60 | 2020-2023 | Nexletol |
| Amarin Pharma, INC. | $81.00 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $74.76 | 2019-2023 | |
| Baxter Healthcare | $73.57 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.24 | 2019-2025 | Jardiance |
| Philips North America LLC | $66.22 | 2020 | |
| Biotronik INC. | $58.48 | 2021 | |
| Scpharmaceuticals INC. | $52.64 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.62 | 2021-2022 | |
| Novo Nordisk INC | $46.33 | 2025 | Wegovy |
| Medtronic, INC. | $38.37 | 2024-2025 | Hawkone, Venaseal |
| Itamar Medical INC | $36.87 | 2023 | Watchpatone |
| Akcea Therapeutics, INC. | $28.58 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $26.65 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $25.08 | 2019-2022 | |
| Stryker Corporation | $21.08 | 2025 | Flowtriever |
| Cvrx, INC. | $20.68 | 2024 | Barostim Neo System |
| Irhythm Technologies, INC. | $15.63 | 2024 | Zio Xt Patch, Zio Monitor |
| Cardiovascular Systems INC. | $14.88 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehul Bhalja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.